Viking Global Investors

Holding/activity history for  Royalty Pharma plc (RPRX)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2023   Q4 10,087,417 1.04 Add 6.58% 0.06 $28.09
2023   Q3 9,464,201 1.05 Reduce 3.93% 0.04 $27.14
2023   Q2 9,850,932 1.24 Reduce 12.08% 0.17 $30.74
2023   Q1 11,204,249 1.90 Add 11.95% 0.20 $36.03
2022   Q4 10,008,511 1.99 Reduce 8.02% 0.17 $39.52
2022   Q3 10,881,594 2.03 Reduce 12.04% 0.28 $40.18
2022   Q2 12,370,694 2.39 Add 14.92% 0.31 $42.04
2022   Q1 10,764,472 1.70 Add 4.35% 0.07 $38.96
2021   Q4 10,315,378 1.19 Add 149.13% 0.71 $39.85
2021   Q3 4,140,508 0.42 Add 27.85% 0.09 $36.14
2021   Q2 3,238,654 0.40 Add 57.08% 0.15 $40.99
2021   Q1 2,061,753 0.27 Reduce 9.85% 0.03 $43.62
2020   Q4 2,287,000 0.31 Add 17.40% 0.05 $50.05
2020   Q3 1,948,064 0.30 Reduce 22.54% 0.09 $42.07
2020   Q2 2,514,985 0.53 Buy 0.53 $48.55